Queen's University at Kingston
- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 1841-10-16
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.queensu.ca
Effects of N-acetylcysteine on Cardiorespiratory Control in COPD Patients With Mild-to-moderate Airflow Obstruction
- Conditions
- Interventions
- First Posted Date
- 2015-10-20
- Last Posted Date
- 2018-06-14
- Lead Sponsor
- Queen's University
- Target Recruit Count
- 13
- Registration Number
- NCT02579772
Inspiratory Muscle Training for Breathless Patients With Chronic Obstructive Pulmonary Disease and Heart Failure
- First Posted Date
- 2015-10-19
- Last Posted Date
- 2016-10-18
- Lead Sponsor
- Queen's University
- Target Recruit Count
- 50
- Registration Number
- NCT02579200
- Locations
- 🇧🇷
Universidade Federal do Rio Grande do Sul/Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil
🇧🇷Universidade Federal de São Paulo, Sao Paulo, SP, Brazil
🇧🇪KU Leuven, Leuven, Belgium
Hati Salama (Secure Voucher)
- Conditions
- Interventions
- First Posted Date
- 2015-09-28
- Last Posted Date
- 2016-04-13
- Lead Sponsor
- Queen's University
- Target Recruit Count
- 5219
- Registration Number
- NCT02561624
- Locations
- 🇹🇿
Pamoja Tunawez, Moshi, Tanzania
Comparability and Standardization of Controlled Allergen Challenge Facilities
- First Posted Date
- 2015-09-07
- Last Posted Date
- 2019-04-09
- Lead Sponsor
- Queen's University
- Target Recruit Count
- 98
- Registration Number
- NCT02543346
- Locations
- 🇺🇸
Biogenics Research Chamber, San Antonio, Texas, United States
🇨🇦Kingston General Hospital, Kingston, Ontario, Canada
Pilot RCT to Test Effectiveness of the ACE4 (Activity Challenge- 4 Areas) for Depression and Anxiety
- First Posted Date
- 2015-09-02
- Last Posted Date
- 2015-09-02
- Lead Sponsor
- Queen's University
- Target Recruit Count
- 120
- Registration Number
- NCT02538549
- Locations
- 🇨🇦
Addiction & Mental Health Services - Kingston Frontenac Lennox & Addington, Kingston, Ontario, Canada
Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy Regimens
- Conditions
- Interventions
- First Posted Date
- 2015-09-01
- Last Posted Date
- 2024-02-12
- Lead Sponsor
- Canadian Cancer Trials Group
- Target Recruit Count
- 153
- Registration Number
- NCT02537418
- Locations
- 🇨🇦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
🇨🇦BCCA - Vancouver Cancer Centre, Vancouver, British Columbia, Canada
🇨🇦Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada
RCT of RESOLVE: A Waiting Room Intervention for Crisis Clients
- Conditions
- Interventions
- First Posted Date
- 2015-09-01
- Last Posted Date
- 2015-09-01
- Lead Sponsor
- Queen's University
- Target Recruit Count
- 140
- Registration Number
- NCT02536924
- Locations
- 🇨🇦
Addiction & Mental Health Services- Kingston Frontenac Lennox and Addington, Kingston, Ontario, Canada
Action-Based Cognitive Remediation to Improve Vocational Outcomes in Depression
- Conditions
- Interventions
- First Posted Date
- 2015-08-28
- Last Posted Date
- 2018-11-14
- Lead Sponsor
- Queen's University
- Target Recruit Count
- 73
- Registration Number
- NCT02535390
- Locations
- 🇨🇦
Queen's University, Kingston, Ontario, Canada
Wearable Technology for Hospital Inpatients
- Conditions
- First Posted Date
- 2015-08-19
- Last Posted Date
- 2016-04-05
- Lead Sponsor
- Queen's University
- Target Recruit Count
- 50
- Registration Number
- NCT02527408
- Locations
- 🇨🇦
Kingston General Hospital, Kingston, Ontario, Canada
Study Comparing Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy (CRT) for Spinal Metastases
- First Posted Date
- 2015-07-31
- Last Posted Date
- 2024-02-13
- Lead Sponsor
- Canadian Cancer Trials Group
- Target Recruit Count
- 229
- Registration Number
- NCT02512965
- Locations
- 🇨🇦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
🇦🇺Peter Mac - Sunshine Hospital, St Albans, Victoria, Australia
🇨🇦Cross Cancer Institute, Edmonton, Alberta, Canada